AGT and Stroke: As presented in Table 2, a statistically not significant reduction in LV stroke volume (51.78 ± 12.76 baseline vs. 43.78 ± 7.71 mL follow‐up, P = 0.0671) was observed in the ANG II‐treated group, but not in the control group (55.6 ± 6.65 vs. 51.2 ± 15.51, P = 0.5172).